FDA Adverse Event Malfunction Summary report: N

BN PROSPEC SYSTEM

MDR report key: 12252028 · Received July 30, 2021

Report

Report Number
9610806-2021-00053
Event Type
Malfunction
Date Received
July 30, 2021
Date of Event
June 29, 2021
Report Date
July 30, 2021
Manufacturer
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
Product Code
JZW
UDI-DI
00630414002736
PMA / PMN Number
K001647
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
SW
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THE CUSTOMER CONTACTED A SIEMENS CUSTOMER CARE CENTER (CCC). QUALITY CONTROLS (QC) RECOVERED IN RANGE AT THE TIME OF THE EVENT. THE ISSUE WAS LIMITED TO THE INITIAL SAMPLE DETERMINATION FOR FREE LIGHT CHAINS, TYPE LAMBDA (FLC LAMBDA) FOR ONE PATIENT SAMPLE. THERE ARE NO REPORTS OF OTHER SAMPLES AFFECTED. THE CAUSE OF THE EVENT IS UNKNOWN. THE SYSTEM IS PERFORMING ACCORDING TO SPECIFICATIONS. NO FURTHER EVALUATION OF THIS DEVICE IS REQUIRED.

Description of Event or Problem · 1

A DISCORDANT, FALSELY LOW FREE LIGHT CHAINS, TYPE LAMBDA (FLC LAMBDA) RESULT WAS OBTAINED ON A PATIENT SAMPLE ON A BN PROSPEC SYSTEM USING N LATEX FLC LAMBDA REAGENT. THE DISCORDANT RESULT WAS NOT REPORTED TO THE PHYSICIAN(S). THE ELECTROPHORESIS FOR THE AFFECTED SAMPLE SHOWED A HIGHER RESULT, SO THE SAMPLE WAS RERUN TWO TIMES FOR FLC LAMBDA ON THE BN PROSPEC SYSTEM THREE DAYS LATER, ONCE USING A 1:100 AND ONCE USING A 1:400 DILUTION, RECOVERING HIGHER. THE RESULT OBTAINED USING THE 1:400 DILUTION WAS REPORTED, AS THE CORRECT RESULT, TO THE PHYSICIAN(S). THREE DAYS LATER, THE SAMPLE WAS RERUN FOUR MORE TIMES FOR FLC LAMBDA ON AN ATELLICA NEPH 630 SYSTEM, ONCE USING 1:20 DILUTION, ONCE USING A 1:100 DILUTION, AND TWICE USING A 1:400 DILUTION, ALSO RECOVERING HIGHER AND MATCHING THE HIGHER REPEAT RESULT OBTAINED ON THE BN PROSPEC SYSTEM. A NEW SAMPLE FROM THE SAME PATIENT WAS RUN THREE TIMES FOR FLC LAMBDA ON THE ATELLICA NEPH 630 SYSTEM, ONCE USING 1:20 DILUTION, ONCE USING A 1:100 DILUTION, AND ONCE USING A 1:400 DILUTION, MATCHING THE HIGHER RESULTS FROM THE PREVIOUS SAMPLE. NONE OF THE RESULTS FROM THE ATELLICA NEPH 630 SYSTEM WERE REPORTED TO THE PHYSICIAN(S). THERE ARE NO KNOWN REPORTS OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCES DUE TO THE DISCORDANT, FALSELY LOW FLC LAMBDA RESULT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1152706 BN PROSPEC SYSTEM BN PROSPEC SYSTEM JZW SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH BN PROSPEC SYSTEM 00630414002736

Patients

Seq Age Sex Outcome Treatment
1